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5DECRIMINALIZATION OF DRUGS IN 
PORTUGAL: A CONTROVERSIAL  
EXPERIMENT FOR PUBLIC HEALTH
Kathryn Kundrod
Introduction
 Portugal has received international at-
tention since 2001, when it decriminalized the 
personal use of all illicit drugs (Hughes and 
Stevens, 2012, p. 110).1 This policy has been po-
larizing, as various interest groups have taken 
extreme positions in analyzing whether or not it 
has been a success (Hughes and Stevens, 2012, 
p. 101). In practice, drug policy is difficult to as-
sess due to a variety of factors, including public 
knowledge of the legal status of drugs, user sen-
sitivity to criminal penalties, and the dynamics 
of the illicit drug market (Yablon, p. 4). Further-
more, the data available to ascertain the suc-
cess of a drug policy often fall short in their 
comprehensiveness and accuracy, which leads 
to uncertainty in any conclusions drawn from 
them. In addition, selective data use can lead 
to divergent accounts of the same situation 
(Hughes and Stevens, 2012, p. 109). However, 
despite the controversy, polarized perspectives, 
difficulties in data collection and selection, and 
the complexity of the drug policy itself, the 
Portuguese drug policy experiment has argu-
ably caused major societal changes in public 
health and criminal justice outcomes. 
 The aim of this article is to assess the 
effects of the drug decriminalization program 
in Portugal as they relate to public health and 
criminal justice. The methods I used to ac-
complish this assessment include analyzing 
trends before and after the policy change and 
comparing them to trends in other appropriate 
countries. Through this analysis, it is evident 
that after the Portuguese policy change there 
were decreases in drug-related deaths, in the 
incidence of drug-related infectious diseases, 
and in rates of problematic drug usage. Fur-
ther, the criminal justice system was burdened 
with fewer drug-related crimes. However, 
 1Decriminalization means the removal of all crimi-
nal sanctions and implementation of administrative sanc-
tions (van het Loo et al., p. 50). I discuss this in detail in the 
section “Drug Policy Design.” 
6there were also modest increases in recreation-
al drug usage rates. These trends in Portugal 
differed from general trends in the rest of Eu-
rope in that there were larger decreases in HIV 
incidence, in problematic drug usage, and in 
the burden on the criminal justice system and 
smaller increases in casual drug usage in Por-
tugal. This comparison in trends leads to the 
conclusion that this policy has generally been 
successful. The major factor leading to this 
success seems to be Portugal’s focus on public 
health initiatives (Russoniello, p. 395).
 After an historical overview of drug policy 
in Portugal, I describe the 2001 policy change 
that decriminalized drugs. I then discuss gen-
eral drug policy design and explore the ef-
fects of the decriminalization policy on public 
health, drug use, treatment demand, and crim-
inal justice. Finally, I discuss the effects of the 
austerity program that Portugal was mandated 
to follow on the impact of the decriminaliza-
tion program.
Historical Overview of Portugal’s 
Drug Policy
 Until 1963 Portugal had passed very lit-
tle illicit drug legislation; however, in 1963 it 
passed a mental health law that identified drug 
addiction treatment as a component of mental 
healthcare, although at the time there were no 
facilities or plans to provide federal drug ad-
diction treatment. Shortly thereafter, Portugal 
implemented a legal framework for the crimi-
nalization of drugs. Under this framework, per-
sonal possession could warrant a punishment 
of up to two years’ imprisonment (EMCDDA, 
2011a, p. 10). This policy aligned with guide-
lines produced by the United Nations Conven-
tions of 1961 (George et al., p. 38).
 The rhetoric surrounding drug poli-
cy debates during the 1960s focused mainly 
on the moral aspects of drug use. This focus 
slowly shifted in the 1970s with the creation 
of the Centro de Estudos da Juventude (Youth 
Studies Center) and the Centro de Investi-
gação Judiciária da Droga (Drug Criminal In-
vestigation Center). These centers, which had 
been created because of the increase in drug 
experimentation that occurred after the demo-
cratic revolution of 1974,2 aimed to study both 
the supply and demand sides3 of drug policy. 
Through their reports, these two centers shift-
ed the rhetoric on drug use, encouraging a hu-
manistic perspective of drug users by observing 
drug use through a public health rather than 
a criminal lens (EMCDDA, 2011a, p. 10). As a 
result of their investigations, the Youth Studies 
Center produced the first recommendation of 
drug decriminalization in 1976. 
 In a move that reversed the progress 
made by the Youth Studies Center, Portu-
gal moved the oversight of drug policy to the 
Ministry of Justice in 1982 for budgetary and 
operational reasons. Soon thereafter, Portugal 
adopted a new legal framework that increased 
focus on drug trafficking while maintaining so-
cial condemnation of the drug user. However, 
alongside the legal criminalization of drug use, 
this new framework also recognized the need 
to provide treatment for the user, leading to 
the creation of the first drug treatment cen-
ters, which brought the Ministry of Health into 
drug policy. 
 In 1987 the first comprehensive drug 
policy addressing both supply and demand re-
duction was implemented. This policy, called 
Projecto VIDA, was enacted due to increasing 
heroin usage and drug trafficking. Projecto 
VIDA comprised 30 measures, including the 
first official national call for treatment and 
social rehabilitation. Notably, Projecto VIDA 
contained measures to increase resources for 
people with AIDS and for AIDS prevention as 
well as a shift of control over treatment cen-
ters from the Ministry of Justice to the Ministry 
of Health. In 1993 the first syringe-exchange 
and HIV testing programs were implemented 
alongside a new policy for supply reduction, 
which remain in effect today. As the public 
health focus of demand-side drug policy began 
to grow larger in the 1990s, there was a call for 
a more integrated policy from representatives 
of all political parties (EMCDDA, 2011a, p. 86).
 2Through a military coup, Portugal ended a 48-year-
old dictatorship on April 25, 1974. By 1976, Portugal 
had written a democratic constitution (Chabal, p. 233). 
 3Supply side refers to manufacture, trafficking, and 
sale; demand side refers to possession and consumption 
(Yablon, p. 3).
7The 2001 Policy Change: “Treat  
Rather than Punish”
 The drug situation in Portugal remained 
problematic and seemed to be worsening at 
the end of the 1990s despite the government’s 
policies to curb drug usage, such as Projecto 
VIDA. This was exemplified through rising HIV 
incidence and problematic heroin usage rates 
(Hughes and Stevens, 2007, p. 3). Therefore, 
the government assembled the Commission 
for a National Drug Strategy (CNDS) (van het 
Loo et al., p. 50), composed of nine individuals, 
to tackle the drug problem. The commission 
included five legal or health experts in drug 
policy theory, two from the Health and Justice 
Ministries, the Assistant Minister to the Prime 
Minister, and a noted researcher with no ties to 
drug policy. The CNDS put together a report 
for Parliament, which was approved unani-
mously and adopted into the policy that took 
effect in 2001 (EMCDDA, 2011a, p. 15). The 
policy reflected a central desire to “treat [rath-
er] than punish” (Trigueiros et al., p. 1)4 with a 
“key rationale for the reform [being] to provide 
a more health-oriented response, including the 
possibility to refer people who are dependent 
on drugs into treatment” (Hughes and Stevens 
2010, p. 1001).5 More generally, the primary 
goal of the policy change was “to implement a 
coherent and comprehensive strategy based on 
the philosophy of harm reduction, in the broad 
sense of referring to activities that reduce harm 
to the drug-consuming individual and society” 
(van het Loo et al., p. 54). 
 The goal of this policy change utilized 
the central principles outlined by the CNDS to 
define 13 strategic options central to the 2001 
policy (van het Loo et al., p. 56). These princi-
ples were 
 1. International cooperation 
 2. Decriminalization of all illicit drugs 
  for personal consumption 
 3. A focus on prevention
 4. Improved access and quality of  
  treatment for addicts 
 5. Extended harm-reduction policies 
 6. Social and professional reintegration  
  programs 
 7. Harm reduction in prisons 
 8. Treatment as an alternative to prison 
 9. Increased scientific research on drugs 
  and drug addiction 
 10. Establishment of methodologies for  
  policy evaluation 
 11. Simplified oversight 
 12. Reinforced targeting of drug trafficking 
 13. Increased public investment. 
 Decriminalization was just one of the 
many public health-related principles that 
went into the creation of this policy. Along 
with these 13 strategic options were several 
guiding principles. One guiding principle was 
humanism, the recognition of human rights 
for all people, meaning that people addicted to 
drugs should receive social services. A second 
guiding principle was pragmatism, ensuring 
that interventions are scientifically based. The 
implementation of these strategic options and 
principles occurred under the National Action 
Plan for the Fight Against Drugs and Drug Ad-
diction, which took effect in 2001 (EMCDDA, 
2011a, p. 15). 
 In order to carry out the new policy, 
Portugal created new oversight mechanisms.6 
The Institute on Drugs and Drug Addiction 
(IDT), which grew out of the former Projecto 
VIDA, moved to the Ministry of Health in 2002. 
 
 6A portion of the funding for drug control in Por-
tugal comes from lottery receipts and money seized from 
traffickers. More than 90 percent of this funding is devot-
ed to treatment, not punishment. In the U.S., “the cost of 
running the state-prison systems has grown by 400 per-
cent [since the late 1980s], and it is expected to grow even 
more rapidly in the next decade. According to the National 
Center on Addiction and Substance Abuse, these costs rep-
resent at least ten times the amount of money spent on 
treatment, prevention, and research” (Specter).
 4The relative merits of treatment and punishment 
as related to illicit drug usage are still debated today. As re-
ported by Specter, “There is no country where illegal drugs 
kill as many people as legal addictive substances. The World 
Bank estimates that tobacco will kill five hundred million of 
the present global population” (Specter). Therefore, wheth-
er the legal status of certain drugs takes into consideration 
their public health impact (i.e., their cause of health-relat-
ed harms) is debated. An alternative theory is that drugs 
were originally deemed licit or illicit based on socioeco-
nomic factors, largely neglecting public health (Specter). 
 5This is in comparison to other reforms that focus 
solely on avoiding criminal penalties for drug users instead 
of focusing on health, as is the case in Mexico (Hughes and 
Stevens 2010, p. 1001). A comprehensive comparison of the 
goals and outcomes of each policy is described in Russoniello.
8Furthermore, the new law established Com-
missions for the Dissuasion of Drug Abuse 
in each of Portugal’s administrative districts 
under the jurisdiction of the IDT (EMCDDA, 
2011a, p. 17). Each commission was composed 
of three people, two from the medical sector 
and one with a legal background. The only 
function of these commissions is to administer 
sanctions for drug use. Examples of sanctions 
are fines (ranging from €25 to €150), travel 
bans, restraining orders, removal of profes-
sional licenses, scheduled meetings with the 
committee, and gun restrictions. Sanction de-
cisions are to be made based on several factors, 
including the drug type, severity of offense, 
whether use occurred in public or private, 
whether the user was an addict, and the user’s 
socioeconomic status (van het Loo et al., p. 58).
Drug Policy Design
 In order to analyze the change in drug 
policy in Portugal, I discuss general drug poli-
cy design. There are four general types of drug 
policy: prohibition, decriminalization, depe-
nalization, and legalization. Consequences for 
drug use differ under each type of policy. In 
order to assess drug policy, the distinctions be-
tween prohibition, decriminalization, depenal-
ization, and legalization should be clear. Table 
1 shows the consequences under each frame-
work for getting caught with a small amount of 
drugs (i.e., an amount deemed appropriate for 
use and not sale).
 Although some countries did not ad-
here, the global policy trend in the 1980s was 
toward harsher prohibition at all levels. How-
ever, in trying to combat drug-related issues, 
many countries have since reversed this trend 
(Greenwald, p. 2), aligning with the side of 
the drug policy debate that discredits the ef-
fectiveness of prohibition schemes (Miron and 
Zwiebel, p. 176). Although no country has ful-
ly legalized drugs, many have decriminalized 
or depenalized them.7 
 The rationale for criminalizing the sup-
ply side is to prevent people from beginning to 
use drugs and limit normalization of drug use 
so that it does not spread throughout society 
(Babor, p. 75). Conversely, the rationale for 
decreasing criminal penalties on the demand 
side generally reflects claims that the criminal 
justice system tends to exacerbate drug abuse 
(Greenwald, p. 1). Table 2 presents the strate-
gies relevant to Portugal where interdiction 
remained intact to deter trafficking and sale 
through criminalization. While criminal sanc-
tions were upheld on the supply side, they were 
eliminated on the demand side. Furthermore, 
services for drug users and harm-reduction 
strategies were increased with goals of promot-
ing public health and decreasing drug usage.
 The complexity of creating and analyzing 
drug policy is a result of many factors, includ-
ing knowledge of drug laws, behavioral changes 
related to criminal penalties, unrelated changes 
in the drug market, and data scarcity surround-
ing decriminalization events (Yablon, p. 4). The 
European Monitoring Centre for Drugs and 
Drug Addiction (EMCDDA) was established to 
provide information to the European Union 
(EU) and its member states regarding drug 
issues in an attempt to mitigate data scarcity 
and increase public knowledge of drug policy. 
It is arguably the most comprehensive source 
available for professionals and policymakers 
in assessing drug policy in Europe, as the re-
searchers at EMCDDA both perform their own 
research and compile reports from other orga-
nizations and governments. The methods used 
to analyze the data provided by the EMCDDA 
and other organizations are important in mini-
mizing issues associated with drug policy anal-
ysis, as discussed in the following section.
Approaches to Policy Evaluation
 I provide an analysis of the effectiveness 
of Portugal’s drug policy. Ideally, the best use 
of data would be an analysis of trends in an 
extended time series, including years before 
and after the “treatment”—the drug policy re-
form (Campbell, p. 413). Following Campbell’s 
guide to assessing reforms, my hypothesis is 
that the drug policy reform caused the changes 
in public health and criminal justice observed 
in Portugal. The rival hypothesis is that all the 
changes would have happened regardless of 
 7Since the “War on Drugs” was declared in 1971, the 
United States has been following a prohibitionist framework 
with severe criminal penalties (NPR).  However, in recent 
years, Colorado, Washington, Oregon, Alaska, and Washing-
ton, D.C. have legalized marijuana for recreational use, and 
several states and cities have decriminalized it (Nelson).
9policy reform. In order to determine whether 
changes in trends after the policy reform would 
have happened regardless, the indicator trends 
over the same years need to be compared to an 
appropriate country or countries. I have cho-
sen Spain as the benchmark country for com-
parison purposes not only for its proximity to 
Portugal but also for its comparable drug situa-
tion.8 Italy is similarly appropriate for compar-
ison (Hughes and Stevens, 2010, p. 1003), and 
I use it as a benchmark when possible.
 Presentations of data in this format—
trends from before and after 2001 over the 
same periods measured by the same criteria 
for Portugal, Italy, and Spain—would be a fair-
ly comprehensive and consistent analysis of 
the effects of the drug decriminalization pro-
gram in Portugal, avoiding bias based on data 
selection. Unfortunately, data often do not ex-
ist over the same periods of time for all three 
countries of interest and, when they do exist, 
they are sometimes not measured according 
to the same criteria. To preserve data integrity, 
I analyze data over the longest possible peri-
od of time in order to identify trends. Finally, 
 8Spain created a policy in 1992 that made drug use 
illegal but never criminalized drug use. Before 1992, drug 
use and possession were allowed under Spanish law. How-
ever, compared to Portugal, Spain puts much less emphasis 
on public health programs (EMCDDA, 2012a). Another key 
difference is that Spain’s decriminalization system is de fac-
to, meaning that the user goes through the criminal justice 
system but does not ultimately face criminal penalties. In 
Portugal, drug users go through the public health system 
under the Ministry of Health, not the Ministry of Justice 
(Russoniello, p. 386).
Source: Adapted from Yablon, p. 3.
Source: Adapted from Babor, pp. 75 and 78.
Table 1
General Consequences for Possessing Drugs for Personal Use
Table 2
Supply- and Demand-Based Strategies Relevant to Portuguese Drug Policy 
Framework Illegal? Criminal Record? Maximum Penalty
Prohibition Yes Yes Imprisonment
Depenalization Yes Yes Fines
Decriminalization Yes No Fines
Legalization No No N/A
Strategy Supply or 
Demand
Targeted Policy Broad Policy Goals
Interdiction Supply Arrest traffickers/dealers, force 
suppliers to operate in inefficient ways
Keep prices high and 
reduce availability
Eliminate criminal 
sanctions
Demand Decrease penalties for drug use Prevent negative effects 
of criminalization
Services for drug 
users
Demand Counseling, therapeutic communities, 
needle exchange programs, and peer-
support groups
Reduce crime and over-
dose deaths and treat 
psychiatric disorders
Harm-reduction 
strategies
Demand Safe injection sites and needle 
exchange programs
Prevent spread of HIV 
infection and reduce risk 
of overdose death
10
present qualitative research to bridge the gap 
between the intended effects of the policy and 
the effects of the policy that were observed by 
users and administrators. 
Results of Policy Evaluation
 Although most analysts of Portugal’s 
drug decriminalization claim it has been a suc-
cess, some have called it a “disastrous failure” 
(Hughes and Stevens, 2012, p. 101). Those who 
oppose decriminalization believe that harm- 
reduction measures decrease the pressure to 
stop using drugs. The most vocal opposition 
to the policy has come from Dr. Manuel Pin-
to Coelho, who believes that “medicalization 
of this deviant behavior… convinces most ad-
dicts that they have to remain dependent on 
methadone rather than struggle to become 
independent. It is a service neither to them 
nor to society” (Specter). Pinto Coehlo has 
written many articles critical of Portugal’s pol-
icy. Glenn Greenwald has a different view from 
Pinto Coelho’s. Greenwald argues that “none of 
the fears promulgated by opponents of Portu-
guese decriminalization has come to fruition, 
whereas many of the benefits predicted by drug 
policymakers from instituting a decriminaliza-
tion regime have been realized” (Greenwald, 
p. 28). In 2012 Hughes and Stevens analyzed 
the methods used by Pinto Coehlo and Gre-
enwald, the two analysts who have come out 
with arguably the most negative and positive 
reviews of the policy. From this review, it be-
came clear that both Pinto Coehlo and Green-
wald selectively used data to support their dif-
ferent points of view. Examples of this include 
focusing on indicators in a single year or short 
period of time rather than trends (Hughes and 
Stevens, 2012, p. 110). 
 By comparing trends in Portugal with 
trends in appropriate control countries (Spain 
and Italy) when possible, Hughes and Stevens 
(2007, p. 9) found that there have been an in-
creased use of cannabis, a decreased use of her-
oin, an increased demand for treatment, and a 
reduction in drug-related deaths in Portugal. 
Others have reiterated these conclusions and 
have generally categorized decriminalization 
as a success. Many issues that have been suc-
cessfully addressed by decriminalization, such 
as lower rates of problematic drug usage and 
lower rates of HIV incidence, continue to be 
problematic in many EU states that did not 
decriminalize drugs (Russoniello, p. 391). Us-
ing the methodology described in the previous 
section, I performed an analysis of the effects 
of decriminalization on indicators of public 
health, drug usage, treatment demand, and 
criminal justice. The results from this analysis 
are discussed in the following sections. 
 Drug Policy Centralized around  
 Public Health
 According to the United Nations, drug 
policy is a public health issue, and it should 
be used to decrease demand and provide help 
for the user (Johansen and Jones, p. 19). Treat-
ing addiction is a key component of Portugal’s 
policy and is what differentiates it from other 
countries that have decriminalized drugs by 
focusing only on criminal justice aspects, such 
as Spain and Mexico. Elisabeta Moutinho, a 
clinical psychologist working for a drug out-
reach program funded by Portugal’s Ministry of 
Health, argues against resistance to needle-ex-
change programs and other harm-reduction 
measures: 
[Aiding people in their quest to satisfy ad-
dictions] is the wrong way to think about 
what [drug outreach programs] do. Of 
course, you can come here and still buy 
heroin. The dealers know where we are 
and when we are here. People exchange 
syringes and then go buy drugs. I know 
it is not easy for everyone to accept, but 
they don’t get AIDS from a dirty needle, 
or hepatitis. They are not beaten by gangs 
or arrested or put in jail. There is no po-
lice corruption, because there is nothing 
to get rich from. It is a program that re-
duces harm, and I don’t see a better ap-
proach (as quoted in Specter).
 The public health focus, from Moutinho’s 
account, is what allows drug policy to positive-
ly affect harm-reduction outcomes through 
reduced stigma and increased services. I dis-
cuss such outcomes further in the following 
sections.
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 HIV Incidence Rates
 One of the major catalysts for policy change 
in Portugal was a rising HIV incidence rate 
among needle-injecting drug users (EMCDDA, 
2011a, p. 15). I present evidence on the effects 
of drug decriminalization on HIV incidence.9 
Portugal had high HIV incidence rates just pri-
or to the 2001 policy change. In 1999 Portugal’s 
rate of drug-related AIDS and prevalence of HIV 
among injecting drug users (IDUs)10 were first 
and second in the EU, respectively (Hughes and 
Stevens, 2010, p. 1001). At the time of the policy 
change, IDUs were the predominant transmis-
sion group, accounting for 46 percent of all new 
cases (Hamers and Downs, p. 85).
 HIV incidence among IDUs has declined 
significantly since the policy change, illustrat-
ed in Figure 1 (adapted from EMCDDA reports 
on Portugal from 2008 to 2013).11 Hughes and 
Stevens (2010) also reported this trend, cit-
ing “highly significant” drops in HIV—as well 
as in hepatitis C virus (HCV) and tuberculo-
sis—incidence rates among drug users every 
year since decriminalization in their analysis. 
They attribute this largely to the expansion of 
harm-reduction services (pp. 1015–16).
 Due to data scarcity on HIV incidence 
rates, I could only use Spain as a comparison 
from 2004 to 2010, limiting the effectiveness 
of the counterfactual. Nonetheless, analyzing 
the difference between trends over time (see 
Figure 1) still provides a basis for comparison. 
Over this period, the trend in HIV incidence 
rates among non–drug users is nearly identical 
in the two countries. However, the Portuguese 
trend among drug users appears to decline at a 
faster rate than the Spanish trend. The discrep-
ancy between trends indicates that the decrim-
inalization of drugs and associated social pro-
grams created to reduce HIV incidence among 
IDUs appear to have had an effect. This analysis 
is consistent with that of Greenwald, who re-
ports that drug use and associated issues, such 
as HIV incidence, remained high in many EU 
Figure 1 
Comparison of HIV Incidence Rates
Source: Author’s plot based on data from EMCDDA, 2006–2010, 2011b, 2011c, 2012b, and 2013b. 
 9Portugal only started reporting cases of HIV in 2000, 
making it difficult to accurately assess trends before and af-
ter the policy change (Hamers and Downs, p. 84).
 10IDUs refers to individuals who consume drugs 
through intravenous injection. HIV can be spread through 
shared needles for intravenous drug injection.
 11Assuming that the latter years included in Figure 1 
are an underestimate of incidence rates does not negate the 
downward trend that is evident. For the 2006 incidence rate 
discussed in footnote 9, there was an overall increase of 165 
individuals over six years, which is approximately 44 percent 
of the originally reported value. Increasing every value after 
2006 from the original reported values by 44 percent would 
still produce a downward trend since 2000.
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states that adhere to a criminalization scheme 
while it improved in Portugal (p. 11).
 Drug Use
 Rates of recreational (as opposed to prob-
lematic) drug use after the Portuguese policy 
change indicate a slight increase in reported 
illicit drug use among adults; however, the in-
crease in drug use among adults matches in-
creases in Spain and Italy, indicating a regional 
phenomenon. Illicit drug use among adoles-
cents and problematic drug users, however, has 
fallen in Portugal, a trend that is unique and 
opposite to the trends seen in Spain and Italy 
(Hughes and Stevens, 2010, p. 1017). 
 Focusing on problematic drug use is 
important, because the second health-related 
catalyst for the policy change was problem-
atic rates of heroin use. One way to quan-
tify problematic drug use is through drug- 
related deaths. The Wilson Quarterly reports 
that, along with reductions in HIV, HCV, and 
tuberculosis, the greatest success of the 2001 
policy has been reductions in drug-related 
mortality. The IDT reported that the numbers 
of drug-related deaths every year from 2000 
to 2006 were 318, 280, 156, 152, 156, 219, 
and 216, an overall decrease of approximately 
seven percent per year. Over the same years, 
the reported number of toxicological exam-
inations increased 83 percent (from 1,255 to 
2,173) from 2000 to 2006 (Greenwald, p. 18). 
An increase in the number of exams would 
logically result in an increase in the number 
of drug-related deaths reported. However, the 
increase in exams that occurred from 2000 to 
2006 was accompanied by a decrease in the 
reported number of drug-related deaths. The 
reduction in heroin-related deaths was partic-
ularly significant (“Getting High in Portugal”). 
Since the mid-2000s, Portugal has seen an in-
crease in problematic drug use, but this has 
been attributed to the increase in toxicological 
examinations reported by the IDT (Hughes and 
Stevens, 2010, p. 1014). 
 Furthermore, Hughes and Stevens (2010, 
p. 1014) found that the decline in problem-
atic drug use seen in Portugal from 1999 to 
2002 was more pronounced than the declines 
seen in Spain and Italy over the same period 
of time. I extended my comparison through 
the year 2006, the latest year for which data 
are available. From 2000 to 2006 the percent 
rate in decline in drug-related deaths in Spain 
was 18 percent (EMCDDA, 2013c, p. 186), and 
in Italy it was 45 percent (EMCDDA, 2013a, 
p. 141), compared with 32 percent in Portugal 
over the same period. From these data, it is 
unclear whether the change seen in Portugal 
would have occurred regardless of the policy 
change. In order to control for what would 
have occurred without the 2001 policy change, 
Tavares and Portugal (2012) created a synthet-
ic control method for Portuguese drug policy 
analysis. The synthetic control method creates 
a weighted combination of other European 
countries to create an “artificial Portugal,” or 
a simulated Portugal in which there was no 
policy change. From this analysis, Tavares and 
Portugal reported that there would have been a 
higher number of drug-related deaths without 
the change in drug policy.12 
 Treatment Demand
 Along with a decrease in drug-related 
deaths in Portugal, the number of people utiliz-
ing opioid substitution treatment was reported 
to have increased from 6,040 in 1999 to 14,877 
in 2003, and to 17,780 in 2007 (Greenwald, 
p. 15). This trend was also reported in The 
Wilson Quarterly, which noted that treatment 
demand (measured by the number of users en-
rolled in drug treatment programs) increased 
by 60 percent from 1998 to 2008 (“Getting High 
in Portugal”). Specter also reports that from 
1999 to 2009, the percentage of IDUs receiving 
methadone treatments to manage their addic-
tion increased from 37 to 67 percent. Overall, 
between 1998 and 2008 there was an increase 
from 23,654 to 38,532 drug users in treatment 
(Hughes and Stevens, 2010, p. 1015). Over the 
same period of time, the number of drug us-
ers in treatment in Spain remained relatively 
 12The authors note that Portugal has a broader 
definition of drug-related deaths than most other Euro-
pean countries. Portugal defines drug-related deaths as 
any positive result on a toxicological exam, whereas other 
countries classify a death as drug-related when the prima-
ry cause of death is an overdose. This difference may lead 
to over-estimation in Portugal; however, this difference in 
definition is present before and after the policy change, po-
tentially negating its effects.  
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constant, decreasing from 54,338 to 53,155 
(EMCDDA, 2013c, p. 135). Furthermore, the 
number of drug users in treatment in Italy 
increased from 31,510 to 35,020 from 2000 to 
2008 (EMCDDA, 2013a, p. 123), which is a rel-
atively comparable time frame. The percentage 
changes in drug users in treatment over this 
time period for Portugal, Spain, and Italy were 
63, −2, and 11 percent, respectively. These data 
indicate that the utilization of these social pro-
grams in Portugal was greatly enhanced with 
the decriminalization of drugs in 2001 and the 
associated reallocation of resources from in-
carceration to rehabilitation programs. 
 Treatment demand, along with HIV inci-
dence and problematic drug usage rates before 
and after the policy change, are important mea-
sures of the success of the drug decriminaliza-
tion program. The data for these measures in-
dicate that the program was successful because 
it led to lower rates of HIV incidence among 
IDUs and drug-related deaths and higher rates 
of toxicological exams and treatment demand. 
Therefore, it can be reasonably concluded that 
the drug decriminalization program was suc-
cessful from a public health perspective. From 
a comparative study of Portugal, which decrim-
inalized drugs with a focus on public health, 
and Mexico, which decriminalized drugs with 
a focus on criminal justice, it is evident that 
the way in which this policy is supported with 
social programs is crucial (Russoniello, p. 412). 
Consequently, a strong emphasis on public 
health must accompany any recommendations 
of implementing a decriminalization scheme. 
 Criminal Justice
 Decriminalization of personal consump-
tion of drugs does not necessarily indicate a 
soft-on-crime position on drug trafficking or 
drug-related crimes. João Figueira, the chief 
inspector of the drug division of the Judicial 
Police crime squad in Lisbon, changed his po-
sition from opposition to support of the new 
law based on his observations of the ineffective 
results of criminalization in Portugal: 
In the last years before the law, consum-
ers were arrested by police. They were fin-
gerprinted and made statements and took 
mug photos and were presented to court. 
And always, always, always released. It 
was a waste of everyone’s time. It didn’t 
stop drug use or slow down the dealers. 
So the idea that somehow people are 
getting away with what they did not get 
away with before is silly (João Figueira, as 
quoted in Specter).
Instead of letting drug users get away with 
their crimes, the Portuguese program creates 
a reallocation of resources from incarceration 
to treatment of users while allowing for an 
increase in resources to targeting trafficking. 
Hughes and Stevens report a nine percent in-
crease in the number of crimes strongly relat-
ed to drugs (including theft, robberies, public 
assaults, and some cases of fraud) in the years 
2001 to 2005 compared with the years 1997 to 
2001. They also report a 500 percent increase 
in the amount of drugs seized in the years 2000 
to 2004 compared with the years 1995 to 1999. 
Through a comparison of patterns in these 
indicators for Portugal and Spain and Italy, 
Hughes and Stevens (2010, p. 1009) attribute 
the changes to increased law enforcement and 
resources for targeting trafficking rather than 
an increase in the size of the domestic drug 
market. 
 The number of criminal offenses related 
to drugs is expected to drop after decriminal-
ization, because drug users would no longer be 
considered criminals. This turned out to be the 
actual case: there were 14,000 criminal offenses 
related to drugs in 2000, and, in each year since 
decriminalization, there have been between 
5,000 and 5,500 offenses per year (Hughes 
and Stevens, 2010, p. 1008). Accordingly, the 
prison population in Portugal declined con-
tinuously from 2000 to 2012 (Russoniello, 
p. 394). Allen and colleagues argued that this 
decrease resulted in considerable financial sav-
ings for the criminal justice system (p. 4).13 
Additionally, the percentage of offenses com-
mitted under the influence of drugs or to fund 
 13Since 2009, the United States has been making 
more choices to treat rather than punish in order to reduce 
the financial burden on the criminal justice system, includ-
ing drug prevention and treatment programs, diversion of 
nonviolent offenders from the criminal justice system into 
treatment, and more (“Obama Administration Drug Policy: 
A Record of Reform”). According to Specter, “Federal health 
officials have estimated that every dollar spent on sub-
stance-abuse treatment saves the United States seven dollars 
that would be spent on prison, police, and courts.”  
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drug consumption, which is not directly related 
to decriminalization of drug use alone, decreased 
from 44 percent in 1999 to 21 percent in 2008 
(Hughes and Stevens, 2010, p. 1010). 
 Russoniello concludes that the lower per-
centage of drug-related offenders in prison and 
the lower number of people in prison in general 
were both positive outcomes of the decriminal-
ization policy. Without the need to arrest, prose-
cute, and incarcerate drug users, Portugal’s legal 
system appears to have become more efficient 
(Hughes and Stevens, 2010, p. 1009). 
Effects of Austerity
 Portugal was mandated to institute severe 
austerity measures as a condition of receiving fi-
nancing from the International Monetary Fund 
in 2010. In 2011 the EMCDDA observed that the 
austerity measures “have already had an impact 
on drug services.” However, one of the major 
changes occurred in 2012, when Portugal dis-
solved the IDT, the institute in charge of treating 
drug-dependent persons within the Ministry of 
Health (Kirby-Lepesh). In its place, Portugal cre-
ated the General-Directorate for Intervention on 
Addictive Behaviours and Dependencies (Serviço 
de Intervenção nos Comportamentos Aditivos e 
nas Dependências [SICAD]). With this change 
came a decentralization of service provision 
as well. The mission of the SICAD is to reduce 
drug use; but, unlike the IDT, the SICAD oper-
ates regionally rather than nationally (EMCDDA, 
2013b, p. 6). 
 One major implication of the transition 
from the IDT to the SICAD is the location of drug 
treatment centers. The IDT used to control drug 
treatment in specialized facilities; however, un-
der the SICAD, drug users have to go to health 
clinics or hospitals to access treatment, which 
may reintroduce social stigma and intimidation, 
deterring drug users from seeking treatment. An 
example of a specialized facility for treatment is 
Unidade Móvel, a mobile van that is located out-
side of Lisbon and that caters to approximately 
6,000 clients while providing a safe, accessible 
place for drug treatment. The healthcare work-
ers in this van provide access to methadone and 
medication for tuberculosis, HIV, and more, in 
accordance with a doctor’s consent. The van has 
been under the control of IDT, and its future un-
der the SICAD is uncertain (Kirby-Lepesh).
 The future of Portuguese drug policy seems 
especially uncertain now due to the resistance 
to decriminalization shown by Portugal’s right-
wing parties, which favor a prohibitionist ap-
proach (Kirby-Lepesh). The political ideologies 
of the party in power as they relate to the decrim-
inalization program greatly affect the success of 
the program (Russoniello, p. 394). However, the 
current health minister, Paulo Macedo, still sup-
ports the existing drug policies (Kirby-Lepesh). 
Cuts in funding will almost certainly reduce the 
effectiveness of the Commissions for the Dissua-
sion of Drug Abuse, which had been underfund-
ed even before austerity measures. The effects of 
further funding cuts on drug use, treatment up-
take, and drug-related disease are yet to be seen 
(Russoniello, pp. 394–95). 
Conclusion
 Drug decriminalization in Portugal has 
been innovative in its focus on public health and 
social support. The Portuguese decriminalization 
program has led to decreases in drug-related in-
fectious disease and problematic drug usage while 
it has increased treatment demand. By leading 
to a reduction in drug-related crimes, drug de-
criminalization in Portugal has also reduced the 
burden on the criminal justice system. Given the 
success of Portugal’s policy, it would make sense 
to encourage other countries to adopt a similar 
drug policy. Appropriately, during AIDS 2014, an 
international AIDS conference, the World Health 
Organization endorsed decriminalization of il-
licit drug use in order to end HIV transmission 
globally (Global Commission on Drug Policy). 
This call to action, although unlikely to hap-
pen immediately, is gaining more international 
attention. 
 In this article, I have provided evidence that 
drug decriminalization is an important policy re-
form when trying to address drug-related public 
health crises. Decriminalization on its own, how-
ever, cannot solve drug-related public health is-
sues. Programs aimed to help drug users must ac-
company decriminalization. Analysis of the illicit 
drug situation in Portugal indicates that the social 
programs associated with Portugal’s decriminal-
ization policy have been largely responsible for the 
improvements in public health as it relates to illic-
it drugs. Therefore, it is crucial that decriminaliza-
tion occurs with a strong public health focus.
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